Archive · 12 Nov 2025
Novo Nordisk Slashes Wegovy Price in India to Compete with Rivals
A company called Novo Nordisk has made its weight-loss medicine, Wegovy, much cheaper in India.
They lowered the price by almost 40% to help more people afford it.
This is because another similar medicine called Mounjaro has become very popular since it came out a few months ago.
Wegovy wants to sell more too.
The new price for the most expensive Wegovy pack is now around 16,400 rupees a month.
Mounjaro is a bit more expensive for some of its options.
Both these medicines work by mimicking a hormone that helps control blood sugar and makes you feel full, aiding weight loss.
Some studies show Mounjaro might help people lose a bit more weight than Wegovy.
Wegovy's main ingredient will become available for other companies to make in 2026.
Novo Nordisk has reduced the price of its weight-loss drug Wegovy in India by up to 37%.
The highest dose of Wegovy now costs 16,400 rupees monthly, down from 24,389.06 rupees.
This price cut aims to compete with Eli Lilly's Mounjaro, which has seen significant sales since its March launch.
Both Wegovy and Mounjaro are GLP-1 drugs that help lower blood sugar and promote weight loss by increasing fullness.
Studies indicate Mounjaro may lead to greater weight loss compared to Wegovy.
- Who
- Novo Nordisk India
- What
- Reduced the price of its weight-loss drug Wegovy by up to 37% to become more competitive.
- When
- Price cut announced recently; Mounjaro launched in March; Wegovy launched in June.
- Where
- India
- Why
- To gain a larger share of the Indian anti-obesity drug market and compete with rival Eli Lilly's Mounjaro.
Wegovy
Mounjaro
Weight Loss Efficacy
Wegovy
Studies suggest Mounjaro (tirzepatide) resulted in greater weight loss and higher achievement of weight loss targets compared to Wegovy (semaglutide).
Mounjaro
Mounjaro with tirzepatide showed greater weight loss compared to Wegovy in studies.
Market Entry and Sales
Wegovy
Wegovy launched in June and is trying to catch up with Mounjaro's sales.
Mounjaro
Mounjaro launched in March, reported top-selling drug status with Rs 100 cr sales in October, and doubled sales within months.
Pricing
Wegovy
Monthly highest dose (2.4 mg) costs 16,400 rupees, lowest dose (0.25 mg) costs 10,850 rupees.
Mounjaro
Single-dose vial costs between 14,000 to 17,500 rupees monthly; KwikPen (15 mg) costs 27,500 rupees per month.
- Company
- Novo Nordisk (India)
- Drug
- Wegovy (injectable semaglutide)
- Action
- Price reduction of up to 37%
- New Price (Highest Dose)
- 16,400 rupees (previously 24,389.06 rupees)
- New Price (Lowest Dose)
- 10,850 rupees (previously 16,260.94 rupees)
- Competitor Drug
- Mounjaro (tirzepatide) by Eli Lilly
- Mounjaro Pricing
- 14,000-17,500 rupees (single-dose vial), 27,500 rupees (KwikPen, 15 mg)
- Patent Expiry (Wegovy)
- March 2026
Sources
Novo Nordisk drops Wegovy prices by up to 37% on starting dose
Novo Nordisk cuts Wegovy prices by 37% to counter Lilly’s Mounjaro
Novo Nordisk drops Wegovy prices by up to 37% on starting dose
Top Business Updates: Semaglutide Launch Plans, Lenskart Listing, Wular Lake Fish Deaths & More
Novo Nordisk slashes weight-loss drug Wegovy's prices as competition heats up
Emcure Pharma net up 25% at Rs 251 cr in Q2 - Industry News
Novo Nordisk cuts price of its weight loss drug by 37%
Wegovy price-cut part of strategy, not without precedent, says Novo Nordisk India MD
